Several brokerages have updated their recommendations and price targets on shares of ACADIA Pharmaceuticals (NASDAQ: ACAD) in the last few weeks: 12/29/2025 – ACADIA Pharmaceuticals had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings. 12/22/2025 – ACADIA Pharmaceuticals had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings. 12/16/2025 – ACADIA Pharmaceuticals [...]
Weekly Research Analysts’ Ratings Changes for ACADIA Pharmaceuticals (ACAD)
